Previous Close | 40.83 |
Open | 40.77 |
Bid | 41.03 x 100 |
Ask | 41.16 x 200 |
Day's Range | 40.50 - 41.42 |
52 Week Range | 35.69 - 67.66 |
Volume | |
Avg. Volume | 431,255 |
Market Cap | 2.009B |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | 15.81 |
EPS (TTM) | 2.60 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 63.25 |
Amphastar Pharmaceuticals, Inc. ( NASDAQ:AMPH ) shareholders might be concerned after seeing the share price drop 26...
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $41.52, representing a -1% change from its previous close.
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner SVP of Corp. Communication, will ...